Keyphrases
Cocaine
100%
Pentylenetetrazole
78%
Discriminative Stimulus
58%
Diazepam
45%
Cross-tolerance
38%
Stimulus Properties
35%
Drug Discrimination
24%
Cocaine Self-administration
22%
Amphetamine
21%
Morphine
19%
Self-administration
19%
Reinforcing Effect
17%
Ethanol
16%
Chronic Administration
14%
Anxiogenic Drugs
14%
Anxiogenic
14%
Discriminative Stimulus Effects
14%
Interoceptive Stimulus
13%
Stimulus Effects
13%
Fentanyl
12%
Dose-response Curve
12%
Benzodiazepine Withdrawal
11%
Dose Effect
10%
Anxiolytic
10%
Nucleus Accumbens
10%
Catecholamine Biosynthesis
10%
Methylphenidate
10%
Ondansetron
10%
High Dose
9%
SCH23390
9%
Opioids
9%
Progressive Ratio Schedule
9%
Locomotor Activity
9%
Ketamine
9%
Fixed Ratio
7%
Midazolam
7%
Clonidine
7%
Reinforced
7%
Assembly Language
7%
Anxiolytic Drugs
7%
Drug Withdrawal
7%
Drug Dependence
7%
Drug-induced
6%
Stimulus Control
6%
Pentobarbital
6%
Schedules of Reinforcement
6%
Operant Behavior
6%
Intolerance
6%
Drug Effects
6%
Flumazenil
6%
Neuroscience
Pentylenetetrazol
72%
Diazepam
39%
Drug Discrimination
25%
Anxiogenic
24%
Behavior (Neuroscience)
22%
Morphine
20%
Benzodiazepine
19%
Levoamphetamine
17%
Nucleus Accumbens
15%
Fentanyl
11%
Duragesic
11%
Agonist
11%
Metabolic Pathway
10%
Opiate
10%
Anxiolytic
9%
Drug Withdrawal
9%
Locomotor Activity
8%
Catecholamine
8%
Methylphenidate
8%
Clonidine
7%
Pentobarbital
6%
Receptor Antagonist
6%
Midazolam
6%
Flumazenil
5%
Physical Dependence
5%
Benzodiazepine Receptor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pentetrazole
45%
Cross-Tolerance
36%
Diazepam
28%
Dexamphetamine
22%
Sodium Chloride
21%
Methylphenidate
11%
Duragesic
10%
Benzodiazepine
9%
Ketamine
9%
Zofran
8%
Pharmacodynamics
8%
Morphine
8%
Drug Dependence
8%
Midazolam
7%
Anxiolytic
7%
Symptom
5%
Mouse
5%